Crossroads Systems Reports Fiscal Second Quarter 2013

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Crossroads Systems Reports Fiscal Second Quarter 2013 Financial Results

AUSTIN, TX--(Marketwired - Jun 7, 2013) - Crossroads Systems, Inc. ( NASDAQ : CRDS ), a global provider of data archive solutions, reported financial results for its fiscal second quarter ended April 30, 2013.

Revenue for fiscal Q2 2013 was $2.7 million, a decrease of 20 percent from $3.5 million in the same quarter a year ago. Gross profit for fiscal Q2 2013 was $1.9 million, or 70% of total revenue, as compared to $3.1 million or 89% of total revenue in the same quarter a year ago. Operating expenses for fiscal Q2 2013 totaled $5.8 million as compared to $5.1 million in the same period a year ago. 

Net loss for fiscal Q2 2013 totaled $3.9 million or $0.41 per share, as compared to a net loss of $2.1 million or $.19 per share in the same quarter a year ago. At April 30, 2013, cash and cash equivalents totaled $6.0 million, as compared to $2.5 million in the previous quarter.

Management Commentary Richard K. Coleman, Jr., Interim President and CEO at Crossroads Systems, said, "While the second quarter presented us with execution and revenue delivery challenges, I remain extremely optimistic about our future. Very few companies can claim a solid base of revenue from historic products, tremendous potential from a disruptive new product, and an impressive and proven Intellectual Property portfolio. There is no question that we face execution challenges, but we have a dedicated and talented workforce focused on delivering shareholder value from these assets."

Conference Call Information Crossroads will hold a conference call later today (Friday, June 7, 2013) at 10 a.m. Eastern Time (9 a.m. Central Time) to discuss the financial results. Interim President and CEO Richard K. Coleman, Jr., and CFO Jennifer Crane will host the call. A question and answer session will follow management's presentation.

Date: Friday, June 7, 2013 Time: 10 a.m. Eastern Time (9 a.m. Central Time) Dial-In Number: (877) 221-8809 International: (706) 679-8667

To access the live or recorded webcast, visit: http://us.meeting-stream.com/crossroadssystemsinc_060713

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. The conference call will also be available via the company's Web site in the Investor Relations Events & Presentations section. For more information and to view recent press releases, visit www.crossroads.com .

About Crossroads Systems Crossroads Systems, Inc. ( NASDAQ : CRDS ) is a global provider of data archive solutions. Through the innovative use of new technologies, Crossroads delivers customer-driven solutions that enable proactive data security, advanced data archiving, optimized performance and significant cost-savings. Founded in 1996 and headquartered in Austin, TX, Crossroads holds more than 100 patents and has been honored with numerous industry awards for data archiving, storage and protection. Visit www.crossroads.com .

Important Cautions Regarding Forward-Looking Statements This press release includes forward-looking statements that relate to the business and expected future events or future performance of Crossroads Systems, Inc. and involve known and unknown risks, uncertainties and other factors that may cause its actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Words such as, but not limited to, "believe," "expect," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "could," and similar expressions or phrases identify forward-looking statements. Forward-looking statements include, but are not limited to, statements about Crossroads Systems' ability to implement its business strategy, including the transition from a hardware storage company to a software solutions and services provider, its ability to expand its distribution channels, its ability to maintain or broaden relationships with existing distribution channels and strategic alliances and develop new industry relationships, the performance of third parties in its distribution channels and of its strategic alliances and its ability to achieve or maintain profitability. The future performance of Crossroads Systems may be adversely affected by the following risks and uncertainties: uncertainties relating to product development and commercialization, uncertain market acceptance of Crossroads Systems products, including StrongBox, intense competition in the data protection and storage markets, variations in quarterly results and a consequence of unpredictable sales cycles and other factors, the ability to obtain, maintain or protect patent and other proprietary intellectual property rights, technological change in the industry, future capital requirements, regulatory actions or delays and other factors that may cause actual results to be materially different from those described or anticipated by these forward-looking statements. For a more detailed discussion of these factors and risks, investors should review Crossroads Systems' reports on Form 10-K and Form 10-Q filed with the Securities and Exchange Commission, which can be accessed through the SEC's website or by clicking "SEC Filings" on the company's Investor Relations website at http://investors.crossroads.com . Forward-looking statements in this press release are based on management's beliefs and opinions at the time the statements are made. Crossroads Systems undertakes no duty to update this information to reflect future events, information or circumstances.

©2013 Crossroads Systems, Inc., Crossroads and Crossroads Systems are registered trademarks of Crossroads Systems, Inc. All trademarks are the property of their respective owners. All specifications are subject to change without notice.

   
   
   
CROSSROADS SYSTEMS, INC. AND SUBSIDIARIES  
CONSOLIDATED BALANCE SHEETS  
(In thousands, except share data)  
             
    October 31,     April 30,  
ASSETS   2012     2013  
              (Unaudited)  
Current assets:                
  Cash and cash equivalents   $ 6,895     $ 5,953  
  Accounts receivable, net of allowance for doubtful accounts of $102 and $96, respectively     2,847       1,961  
  Inventory     376       298  
  Prepaid expenses and other current assets     309       471  
    Total current assets     10,427       8,683  
                     
Property and equipment, net     1,521       1,386  
Other assets     76       82  
                 
    Total assets   $ 12,024     $ 10,151  
                 
                 
LIABILITIES AND STOCKHOLDERS' EQUITY                
                 
Current liabilities:                
  Accounts payable   $ 1,260     $ 951  
  Accrued expenses     2,879       1,775  
  Deferred revenue     1,306       1,274  
  Current portion of long term debt     2,948       1,501  
                 
    Total current liabilities     8,393       5,501  
                 
Long term liabilities     1,634       1,044  
                 
Commitments and contingencies (See Note 7)     -       -  
                 
Stockholders' equity:                
  Convertible preferred stock, $0.001 par value, 25,000,000 shares authorized, 0 and 4,231,154 shares issued and outstanding, respectively     -       4  
  Common stock, $0.001 par value, 75,000,000 shares authorized, 11,679,860 and 11,845,986 shares issued and outstanding, respectively     12       12  
  Additional paid-in capital     204,582       214,104  
  Accumulated other comprehensive loss     (39 )     (43 )
  Accumulated deficit     (202,558 )     (210,471 )
    Total stockholders' equity     1,997       3,606  
    Total liabilities and stockholders' equity   $ 12,024     $ 10,151  
                     
                     
                     
CROSSROADS SYSTEMS, INC. AND SUBSIDIARIES  
CONSOLIDATED STATEMENTS OF OPERATIONS  
(Unaudited)  
(In Thousands, Except Share and Per Share Data)  
                         
                         
                         
    Three Months Ended     Six Months Ended  
    April 30,     April 30,  
    2012     2013     2012     2013  
Revenue:                                
  Product   $ 1,891     $ 1,046     $ 3,003     $ 2,964  
  IP license, royalty and other     1,562       1,691       3,029       3,324  
                                   
    Total revenue     3,453       2,737       6,032       6,288  
                                 
Cost of revenue:                                
  Product     155       186       236       380  
  IP license, royalty and other     237       622       473       1,376  
                                   
    Total cost of revenue     392       808       709       1,756  
                                 
Gross profit     3,061       1,929       5,323       4,532  
                                 
Operating expenses:                                
  Sales and marketing     1,534       1,909       2,943       3,869  
  Research and development     2,662       2,990       5,419       5,847  
  General and administrative     833       905       1,595       1,781  
  Amortization of intangible assets     47       -       94       -  
                                 
    Total operating expenses     5,076       5,804       10,051       11,497  
                                 
Loss from operations     (2,015 )     (3,875 )     (4,728 )     (6,965 )
                                 
Interest expense     (53 )     (80 )     (103 )     (134 )
Other income     1       5       15       4  
                                 
Net loss   $ (2,067 )   $ (3,950 )   $ (4,816 )   $ (7,095 )
                                 
Dividends and beneficial conversion on preferred stock   $ -     $ (864 )   $ -     $ (864 )
Net loss available to common stockholders, basic and diluted   $ (2,067 )   $ (4,814 )   $ (4,816 )   $ (7,959 )
Net loss per share available to common stockholders, basic and diluted     $ (0.19   )     $ (0.41   )     $ (0.44   )     $ (0.67   )
                                 
Shares used in computing net loss per share:                                
  Available to common stockholders, basic and diluted     11,048,394       11,836,140       11,010,813       11,827,430  
                                 
                                 
                                 
CROSSROADS SYSTEMS, INC. AND SUBSIDIARIES  
CONSOLIDATED STATEMENTS OF CASH FLOWS  
(Unaudited)  
(In thousands)  
             
    Six Months Ended  
    April 30,  
    2012     2013  
                 
Cash flows from operating activities:                
  Net loss   $ (4,816 )   $ (7,095 )
  Adjustments to reconcile net loss to net cash used in operating activities:                
    Depreciation     336       409  
    Non cash interest paid on conversion to preferred stock     -       55  
    Amortization of intangible assets     94       -  
    Gain on disposal of property and equipment     (15 )     -  
    Stock-based compensation     1,179       557  
    Provision for doubtful accounts receivable     30       (5 )
  Changes in assets and liabilities:                
    Accounts receivable     299       894  
    Inventory     (96 )     78  
    Prepaid expenses and other assets     (13 )     (168 )
    Accounts payable     (1,028 )     (313 )
    Accrued expenses     293       (921 )
    Deferred revenue     604       (108 )
      Net cash used in operating activities     (3,133 )     (6,617 )
Cash flows from investing activities:                
  Purchase of property and equipment     (490 )     (273 )
  Purchase of held-to-maturity investments     (185 )     -  
  Maturity of held-to-maturity investments     3,220       -  
      Net cash provided by (used in) investing activities     2,545       (273 )
Cash flows from financing activities:                
  Proceeds from issuance of preferred stock, net of issuance cost     -       7,333  
  Proceeds from issuance of common stock, net of issuance cost     141       27  
  Proceeds from borrowing on debt     3,000       550  
  Repayment of debt     (197 )     (1,963 )
      Net cash provided by financing activities     2,944       5,947  
                 
Effect of foreign exchange rate on cash and cash equivalents     (148 )     1  
Net increase (decrease) in cash and cash equivalents     2,208       (942 )
Cash and cash equivalents, beginning of period     7,336       6,895  
Cash and cash equivalents, end of period   $ 9,544     $ 5,953  
                 
                 
Supplemental disclosure of cash flow information:                
                 
Cash paid for interest   $ 60     $ 74  
Cash paid for income taxes   $ 1     $ 2  
                 
Supplemental disclosure of non cash financing activities:                
                 
Conversion of promissory notes to preferred stock   $ -     $ 605  
                 
                 
                 

Company Contacts: Jennifer Crane Crossroads Systems Email Contact 512.928.6897 or 800.643.7148 Investor Contact: Mark Hood Crossroads Systems Email Contact 512.928.7330 Press Contact: Matthew Zintel Zintel Public Relations Email Contact 281.444.1590

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Apotex Enters U.S. Market with Axitinib Tablets Launch

Updated Category News Views 114

Apotex's Bold Move: Axitinib Tablets Hit the U.S. Market Apotex is shaking things up in the pharma world by launching the first generic version of Axitinib Tablets in the U.S., aimed at treating advanced renal cell carcinoma (RCC) when previous treatments have fallen flat. This isn't just another dance with the red tape—it's a major step for Apotex, flexing their muscle...

Continue Reading
Rock & Roll Hall of Fame's 2026 Induction Triumph

Updated Category News Views 180

A Night of Unstoppable Talent The Rock & Roll Hall of Fame's 2026 Induction Ceremony and boy, what a spectacle it was. Held on a lively Saturday night, November 14, in Los Angeles, it wasn't just an event; it was an electrifying testament to music's profound impact. With the grand ceremony kicking off at the historic city of stars, this year's induction turned the dial to...

Continue Reading
Ross Pools Joins Forces with Florida Panthers in 2026

Updated Category News Views 104

An Unlikely Team-Up: Pools and Hockey Well, here's one for the books: a South Florida pool company hitching its wagon to an NHL team. Ross Pools, the folks who’ve been carving out backyard oases in the sizzling Florida sun for over two decades, are now officially aligned with the Florida Panthers. Yeah, the same Panthers that snatched the Stanley Cup not once but twice...

Continue Reading
Biotech Hit or Miss: Trials and Tribulations

Updated Category News Views 96

Biotech's Roller Coaster: Triumphs and Setbacks Ah, the biotech sector—it's a bit like jumping on a bull, ain't it? You barely hang on when the beast bucks. Monday's market action was downright wild. The S&P 500 didn't have a party, tumbling 1.92%, and the Nasdaq wasn't any friendlier, plummeting 2.49%. Yet, inside this storm, we see some biotech names either catching...

Continue Reading
Hermes AI: A New Era in Market Analysis?

Updated Category News Views 111

Revolution or Just Another App? In a world where stock market insights are as cryptic as hieroglyphs to the average Joe, here comes the Hermes AI Analyzer, breaking onto the scene and promising to translate Wall Street's complex lingo into plain, simple language. It's the brainchild of Turkish engineer Umut Tugrul, who has spent decades in the trenches of software...

Continue Reading
Loyalty Programs Cut $1500 Annually for Consumers

Updated Category News Views 132

Loyalty Programs: An Essential Tool for Households In a world where every dollar counts, retail loyalty programs have become more than just a marketing strategy—they're lifelines for American households scraping through each month. According to fresh research by the Retail Industry Leaders Association (RILA) and conducted by market research leader Circana, these...

Continue Reading
Luxury Villa Cashback Offers Entice Travelers in November

Updated Category News Views 134

A November Bonanza for Villa Bookings Who doesn't love having a few extra bucks in their pocket, especially when they come with the allure of luxury travel? Villas of Distinction is rolling out what they call a 'November Cashback Offer,' and for those with the wallet—and wanderlust—to match, it could be a tempting proposition. Hanging the bait of up to $2,000 cashback...

Continue Reading
Teamsters Ratify Contract, Averting Waste Strike

Updated Category News Views 117

Big Win for Teamsters Local 350 You ever seen a strike averted by sheer willpower and unity? That’s what's happened here with the workers at South San Francisco Scavenger Company. These folks—drivers, mechanics, sorters, and utility workers—all banded together under the Teamsters Local 350 and showed management what's what by securing a contract they deserve. We're...

Continue Reading
Webull Faces FINRA Fine and Legal Battle Ahead

Updated Category News Views 187

Webull's Compliance Headache Webull’s been knocked around again. This time, the Financial Industry Regulatory Authority (FINRA) slapped it with a hefty $4.2 million fine. Talk about a hit to the wallet! It all boils down to them failing to roll out some basic anti-money laundering (AML) and other crucial compliance programs. This is no small oversight, and it's got...

Continue Reading
Ainstein Expands Kansas Operations Amid Sensor Demand Surge

Updated Category News Views 133

Ainstein's Expansion Conquers New Heights in Radar Tech Ainstein just cranked open a whole new chapter right in the heart of Kansas. And believe me, it's not your average ribbon-cutting story. This shiny new facility in Lenexa is locked and loaded to roll out 44,000 radar sensors a year. It's part of a no-nonsense plan to keep up with soaring demand for their tech across...

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking the Future of Health with ELMCRx and ETS Partnership

Updated Category News Views 154

ELMCRx Solutions and ETS Partnership ELMCRx Solutions is forging new paths within the healthcare landscape through its strategic alliance with Emerging Therapy Solutions (ETS). This collaboration is tailored to address the innovative and costly challenges posed by cell and gene therapies (CGT). ELMCRx stands out as a pharmacy benefit manager (PBM) dedicated to providing...

Continue Reading
International Symposium on Microbes and Cancer Research

Updated Category News Views 203

International Symposium on Microbes and Cancer Research Set for March 2-3, the upcoming conference promises to bring together globally recognized experts from various fields related to cancer science. The event, hosted by Tampa General Hospital (TGH) Cancer Institute and the USF Health Morsani College of Medicine, will highlight critical intersections between microbes,...

Continue Reading
Freddie Mac Welcomes Matthew Abrusci as New General Counsel

Updated Category News Views 314

Freddie Mac Names Matthew Abrusci as General Counsel MCLEAN, Va. — Freddie Mac (OTCQB: FMCC) proudly announces the appointment of Matthew D. Abrusci as its new Executive Vice President, General Counsel, and Corporate Secretary. With his extensive experience in financial services, Abrusci is set to make significant contributions to the organization. Matthew Abrusci's...

Continue Reading
Energizer Holdings Declares Increased Dividend for Shareholders

Updated Category News Views 188

Energizer Holdings Announces Dividend for Shareholders Energizer Holdings, Inc. (NYSE: ENR) recently declared a quarterly dividend, highlighting the company’s ongoing dedication to its investors. The Board of Directors determined that each share of common stock will receive a dividend of $0.30, reflecting the organization's solid performance and commitment to returning...

Continue Reading
Tevogen Bio: Pioneering Cost-Effective Innovations in Biopharma

Updated Category News Views 199

Tevogen Bio's Innovative Approach to Healthcare As the biopharma sector navigates an increasingly competitive landscape, Tevogen Bio Holdings Inc. (NASDAQ: TVGN) stands out for its commitment to delivering groundbreaking medical solutions while maintaining affordability. This dedication is crucial as international competitors, particularly from China, develop drugs more...

Continue Reading